Health Condition 1: L819- Disorder of pigmentation, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients of age between 18-60 years. 2.Patients irrespective of gender. 3.Clinically diagnosed patients of melasma of both epidermal and dermal types. 4.Patients who willingly provide written informed consent and are capable of attending follow up appointments.
Exclusion criteria
Exclusion criteria: 1.Pregnant and lactating women. 2.Patients on OCP s and hormonal IUDs. 3.Known cases of malignancies, systemic illnesses like cardiovascular disorders, chronic kidney disease, chronic liver disease and thyroid disease 4.Patients who refuse to give the written consent for the study and unwillingness to come for regular follow up as described in the study plan. 5.Subjects with local inflammatory skin disorders and active herpes infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Change from baseline to day 41st in the mMASI scale (Modified Melasma Area and Severity Index)Timepoint: 40 days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) MELASQOL 2) Change from baseline to day 41st in Photographic images of affected areaTimepoint: 1) 0 day, 10th day, 20th day, 30th day and 41st day 2) 40days | — |
Countries
India
Contacts
Regional Research Institute of Unani Medicine University of Kashmir Srinagar